Several studies have reported that S100A8/A9 has potential as a predictive biomarker in several inflammation-associated diseases such as rheumatism, inflammatory bowel disease, obesity, and atherosclerosis, among others (76, 77). Here, S100A8 is linked to obesity due to melanocortin 4 receptor deficiency.